McFarlane Neil F. sold ZVRA

October 12, 2026 · Form 4 insider transaction

McFarlane Neil F. sold 20,000 shares of Zevra Therapeutics, Inc. at $11.25 per share, a transaction worth $224.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
20,000
Price
$11.25
Total value
$224.9K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 12, 2026
Filing dateOctober 13, 2026
Shares owned after417,225
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Adoption date of referenced 10b5-1(c) plan is: 03-25-2026; This transaction was executed in multiple trades at prices ranging from $11.07 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR